Home Page
Professor Doctor


Infection Diseases
    • Marmara Üniversitesi Tıp Fakültesi
    • İnönü Üniversitesi Turgut Özal Tıp Merkezi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
    • Başkent Üniversitesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı/Yardımcı Doçent, Doçent doktor
    • İstanbul Florence Nightingale Hastanesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Departmanı, Doçent Doktor
    • İstanbul Yeni Yüzyıl Üniversitesi Tıp Fakültesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı Başkanı,
    • İstanbul Yeni Yüzyıl Üniversitesi Gaziosmanpaşa Hastanesi Enfeksiyon Hastalıkları Departmanı/Profesör Doktor

      Uluslararası hakemli dergilerde yayınlanan makaleler (SCI & SSCI & Arts and Humanities)
    • 1• Turan DB, Kuruoglu T, Gumus D, Kalayci F, Serefhanoglu K. Evaluation of Factors that may Cause False Positive Growth Signals in Blood Cultures-As the Word ‘Factors’ will Include Both Microbial and Patients as well as Others.

      Int J Clin Med Microbiol 2018;3:137
    • 2. Derya Bayırlı Turan, Defne Gümüş, Fatma Kalaycı Yüksek, Açelya Gümüş, Kıvanç Şerefhanoğlu, Mine Ang Küçüker. Antibiotic Resistance Rates of Colistin Resistant Gram-Negative Bacteria and a Comparison of Etest and VITEC2 in Evaluation of colistin.

      Acta Microbiologica Bulgarica. 2018;34:52-54.
    • 3. Serefhanoglu K, Oklu E. Kocuria rosea bacteremia: Two case reports and a literature review. Archives of Medical Science Civilisation Diseases.

      Arch Med Sci Civil Dis 2017; 2: e121–e124
    • 4. Turk E, Karagulle E, Serefhanoglu K, Hale Turan, Gokhan Moray. Effect of Cefazolin Prophylaxis on Postoperative Infectious Complications in Elective Laparoscopic Cholecystectomy: A Prospective Randomized Study.

      Iranian Red Crescent Medical Journal. 2013 July; 15(7): 581-6.
    • 5. Serefhanoglu K. Reply to “Non-albicans Candida related candidemia among patients with chronic hemodialysis in the intensive care unit: True incidence or cluster infections?”

      Journal of the Formosan Medical Association 2013;112:439.
    • 6. oooSerefhanoglu K, Timurkaynak F, Can F, Cagir U, Arslan H, Ozdemir FN. Risk factors for candidemia with non-albicans Candida spp. in intensive care unit patients with end-stage renal disease on chronic hemodialysis.

      J Journal of the Formosan Medical Association 2012;111:325-32.
    • 7. Serefhanoglu K, Timurkaynak F, Arslan H, Karakayali H. Bacteremia among liver and kidney transplant recipients: etiologic agents and antimicrobial susceptibilities.

      Braz J Infect Dis. 2011;15:408-9.
    • 8. Turan H, Serefhanoglu K, Karadeli E., Togan T, H Arslan. Osteoarticular involvement among 202 Brucellosis Case identified in Central Anatolia region of Turkey.

      Intern Med. 2011;50:421-8.
    • 9. Azap OK, Arslan H, Serefhanoglu K, Colakoglu S, Erdogan H, Timurkaynak F, Senger SS. Risk factors for extended-spectrum beta-lactamase positivity.

      Clin Microbiol Infect. 2010;16:147-51.
    • 10. Serefhanoglu K, Turan H, Timurkaynak F, Arslan H. Bloodstream Infections Caused by ESBL-Producing E. coli and K. Pneumoniae.

      The Brazilian Journal of Infectious Diseases. 2009;13:411-5.
    • 11. Erbek S, Serefhanoglu K, Erbek S, Demirbilek M, Can F, Tarhan E, Turan H, Cakmak O. Clinical subgroups and antifungal susceptibilities in fungal culture-positive patients with chronic rhinosinusitis.

      Eur Arch Otorhinolaryngol. 2008;265:775-80.
    • 12. Serefhanoglu K, Taskin A, T H, Timurkaynak F, Arslan H, Erel O. Evaluation of oxidative status in patients with brucellosis.

      The Brazilian Journal of Infectious Diseases. 2009;13:249-51.
    • 13. Turan H, Serefhanoglu K, Karadeli E, Timurkaynak F, Arslan H. A case of brucellosis with abscess of the iliacus muscle, olecranon bursitis, and sacroiliitis.

      International Journal of Infectious Diseases. 2009;13:485-7.
    • Turan H, Serefhanoglu K, Torun NA, Kulaksizoglu S, Kulaksizoglu M, Pamuk B, Arslan H. Frequency, risk factors, and responsible pathogenic microorganisms, of asymptomatic bacteriuria in patients with type 2 diabetes mellitus.

      Jpn. J. Infect. Dis. 2008;61:236-8.
    • 15.Serefhanoglu K, Bayindir Y, Ersoy Y, Isik K, Hacievliyagil SS, Serefhanoglu S. Septic pulmonary embolism secondary to dental focus.

      Quintessence International. 2008;39:753-6.
    • 16.Turan H, Arslan H, Azap OK, Serefhanoglu K. In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.

      International Journal of Antimicrobial Agents. 2007;30:186-93.
    • 17.Serefhanoglu K, Ersoy Y, Serefhanoglu S, Aydogdu I, Kuku I, Kaya E. Clinical experience with three combination regimens for the treatment of high-risk febrile neutropenia.

      Ann Acad Med Singapore. 2006;35:11-6.
    • 18.Serefhanoglu K, Turan H, Saba Tonguc, Ozer I, Tosun E, Arslan H. Transfusion-associated graft-versus-host disease in an immunocompetent individual following cardiac surgery.

      Journal Of The Natıonal Medıcal Assocıatıon. 2005;97:418-20.
    • 19.Serefhanoglu K, Turan H, Dogan R, Gullu H, Arslan H. A case of aerococcus urinae septicemia: an unusual presentation and severe disease course.

      Chin Med J. 2005;118:1318-20.
    • 20.Bayindir Y, Sevinc A, Serefhanoglu K, But A. Cervico-mediastınal tuberculous lymphadenitis presenting as prolonged fever of unknown origin.

      J Natl Med Assoc. 2004;96:682-5.
    • 21.Serefhanoglu K, Kaya E, Sevinc A, Aydogdu I, Kuku I, Ersoy Y. Isolated thrombocytopenia: the presenting finding of typhoid fever.

      Clin Lab Haem. 2003; 25:63-5.
    • Serefhanoglu K, DeryaTuran Bayirli, Murathan Uyar, Sinasi Sevmis, Sema Aktas. Ertapenem for bacteraemia in kidney and liver transplant recipients.

      P2426. 29th ECCMID congress, Amsterdam/Netherland, 13-16 April 2019
    • 2.Turk E, Karagulle E, Serefhanoglu K, Turan H, Moray G. The effect of cefazolin prophylaxis on postoperative infectious complication in elective laparoscopic cholecystectomy.

Bht Clinic
Merhaba, size nasıl yardımcı olabiliriz?